rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Fractyl Health, Inc.

GUTS · Nasdaq

Health CareMedical DevicesNot moving yetGLP-1

GUTS stood above a rising 150-day average in 9 of the last 52 weekly readings, and has been out of that trend for the last 38 weeks. It is 80.2% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 38
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$354K
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
72 (-6)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 9 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$374K$0$231KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months7
Sale orders, 12 months0
Buyers · sellers5 · 0
WhoDidSharesTraded
William BradleyDirectorbought64,516at $0.618514 Sep 2026filed 16 Sep 2026
Ajay RoyanDirectorbought23,000at $0.85212 Jun 2026filed 15 Jun 2026
Harith RajagopalanChief Executive Officerbought25,000at $0.730110 Jun 2026filed 11 Jun 2026
Ian SheffieldDirectorbought35,000at $0.729410 Jun 2026filed 11 Jun 2026
William BradleyDirectorbought68,493at $0.734810 Jun 2026filed 11 Jun 2026
Weber Lara SmithChief Financial Officerbought20,000at $0.68548 Jun 2026filed 9 Jun 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders72-6 on the quarter
New · exited12 · 18
Reported value$56.1M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Nantahala Capital Management, LLCreduced · filed 14 Aug 202611,289,096$9.0M-2,075,423−15.5%
Catalio Capital Management, LPadded · filed 14 Aug 20266,168,749$4.9M+676,883+12.3%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20266,096,926$4.8M+563,920+10.2%
BANK OF AMERICA CORPadded · filed 14 Aug 20266,034,147$4.8M+5,909,158+4727.7%
Pale Fire Capital SEreduced · filed 13 Aug 20265,003,237$4.0M-917,808−15.5%
General Catalyst Group Management, LLCreduced · filed 17 Aug 20264,884,186$3.9M-70.0%
Deer Management Co. LLCunchanged · filed 14 Aug 20264,770,901$3.8M00.0%
MAVERICK CAPITAL LTDunchanged · filed 14 Aug 20263,974,806$3.2M00.0%
M28 Capital Management LPunchanged · filed 13 Aug 20261,856,117$1.5M00.0%
BlackRock, Inc.reduced · filed 7 Aug 20261,801,060$1.4M-338,777−15.8%
31 Mar 2024 – 30 Jun 2026
416691Mar 24Sep 24Jun 25Dec 25Jun 26

News

Everyone who traded it

William Bradley Company insiderDirector · last 14 Sep 20263 · 0
Ajay Royan Company insiderDirector · last 12 Jun 20263 · 0
Christopher Charles Thompson Company insiderDirector · last 10 Jun 20260 · 0
Clive Meanwell Company insiderDirector · last 10 Jun 20260 · 0
Harith Rajagopalan Company insiderChief Executive Officer · last 10 Jun 20262 · 3
Ian Sheffield Company insiderDirector · last 10 Jun 20261 · 0
Kelly Ann Barnes Company insiderDirector · last 10 Jun 20261 · 0
Marc Elia Company insiderDirector · last 10 Jun 20260 · 0
Samuel Conaway Company insiderDirector · last 10 Jun 20261 · 0
Weber Lara Smith Company insiderChief Financial Officer · last 8 Jun 20261 · 0
Jay David Caplan Company insiderPresident, Chief Product Off. · last 15 Dec 20250 · 4
Sarah Toomey Company insiderGeneral Counsel · last 15 Dec 20250 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-93.9%
Share count trendFY 2025 · to 1 Mar 20263.4%
Cash and equivalentsFY 2025 · to 31 Dec 2025$81.5M
Free cash flowFY 2025 · to 31 Dec 2025−$90.9M

Analyst forecasts

No analyst forecasts yet.